Authors: TABIBI SE KRZYZANIAK J YALKOWSKY S

Citation: Se. Tabibi et al., DEVELOPMENT OF A MICRO-DISPERSED PARENTERAL FORMULATION OF 17-AAG (NSC-330507), Annals of oncology, 9, 1998, pp. 176-176

Authors: HEIMBECHER S LEE YC TABIBI SE YALKOWSKY SH

Citation: S. Heimbecher et al., MECHANISM OF DANSYLATION OF THE POLYAMINE PENTAAZAPENTACOSANE-CENTER-DOT-5 HCL, International journal of pharmaceutics, 160(1), 1998, pp. 21-29

Authors: LI P VISHNUVAJJALA R TABIBI SE YALKOWSKY SH

Citation: P. Li et al., EVALUATION OF IN-VITRO PRECIPITATION METHODS, Journal of pharmaceutical sciences, 87(2), 1998, pp. 196-199

Authors: HEIMBECHER S LEE YC TABIBI SE YALKOWSKY SH

Citation: S. Heimbecher et al., DERIVATIZATION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ANALYSIS OF PENTAAZAPENTACOSANE PENTAHYDROCHLORIDE, Journal of chromatography B. Biomedical sciences and applications, 691(1), 1997, pp. 173-178

Authors: EZENNIA EI PHILLIPS LR WOLFE TL TABIBI SE

Citation: Ei. Ezennia et al., ANALYSIS OF PERILLIC ACID IN PLASMA BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ULTRAVIOLET DETECTION, Journal of chromatography B. Biomedical sciences and applications, 688(2), 1997, pp. 354-358